Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells.

PubWeight™: 1.87‹?› | Rank: Top 3%

🔗 View Article (PMC 2698096)

Published in Mol Cell on July 20, 2007

Authors

Xiaofen Ye1, Brad Zerlanko, Alyssa Kennedy, Gowrishankar Banumathy, Rugang Zhang, Peter D Adams

Author Affiliations

1: Department of Basic Science, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

Articles citing this

The essence of senescence. Genes Dev (2010) 8.21

WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer (2013) 6.64

Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer (2009) 5.02

Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest (2009) 2.79

PML nuclear bodies. Cold Spring Harb Perspect Biol (2010) 2.44

Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers. Nat Med (2015) 2.41

Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis. Mol Cell (2011) 2.40

Cellular senescence and its effector programs. Genes Dev (2014) 2.37

Tcf3 and Tcf4 are essential for long-term homeostasis of skin epithelia. Nat Genet (2009) 2.07

Cellular senescence and organismal aging. Mech Ageing Dev (2008) 1.92

Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. Cell Rep (2013) 1.74

HMGB2 orchestrates the chromatin landscape of senescence-associated secretory phenotype gene loci. J Cell Biol (2016) 1.46

Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer. Nat Rev Cancer (2012) 1.45

Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence. Cancer Res (2011) 1.29

Global reorganization of the nuclear landscape in senescent cells. Cell Rep (2015) 1.28

Aging by epigenetics--a consequence of chromatin damage? Exp Cell Res (2008) 1.25

Human UBN1 is an ortholog of yeast Hpc2p and has an essential role in the HIRA/ASF1a chromatin-remodeling pathway in senescent cells. Mol Cell Biol (2008) 1.23

Redistribution of the Lamin B1 genomic binding profile affects rearrangement of heterochromatic domains and SAHF formation during senescence. Genes Dev (2013) 1.23

Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling. J Biol Chem (2009) 1.18

Assessing cell and organ senescence biomarkers. Circ Res (2012) 1.17

Physiological and pathological consequences of cellular senescence. Cell Mol Life Sci (2014) 1.15

Myogenic transcriptional activation of MyoD mediated by replication-independent histone deposition. Proc Natl Acad Sci U S A (2010) 1.14

The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence. Neuro Oncol (2011) 1.10

Identification of evolutionarily conserved genetic regulators of cellular aging. Aging Cell (2010) 1.09

Wnt antagonist SFRP1 functions as a secreted mediator of senescence. Mol Cell Biol (2012) 1.06

Senescent mouse cells fail to overtly regulate the HIRA histone chaperone and do not form robust Senescence Associated Heterochromatin Foci. Cell Div (2010) 1.05

Wnt activity and basal niche position sensitize intestinal stem and progenitor cells to DNA damage. EMBO J (2015) 1.04

Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases. Alzheimers Res Ther (2009) 1.00

A comparison of oncogene-induced senescence and replicative senescence: implications for tumor suppression and aging. Age (Dordr) (2014) 0.98

E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis. Blood (2012) 0.97

BRG1 is required for formation of senescence-associated heterochromatin foci induced by oncogenic RAS or BRCA1 loss. Mol Cell Biol (2013) 0.95

Global heterochromatin loss: a unifying theory of aging? Epigenetics (2012) 0.95

The Wnts of change: How Wnts regulate phenotype switching in melanoma. Biochim Biophys Acta (2015) 0.95

The effect of physiological stimuli on sarcopenia; impact of Notch and Wnt signaling on impaired aged skeletal muscle repair. Int J Biol Sci (2012) 0.94

Long noncoding RNAs(lncRNAs) and the molecular hallmarks of aging. Aging (Albany NY) (2014) 0.92

HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of neoplasia. Genes Dev (2014) 0.89

Effects of age and gender on WNT gene expression in human bone marrow stromal cells. J Cell Biochem (2009) 0.88

Wnt-signaling and senescence: A tug of war in early neoplasia? Cancer Biol Ther (2008) 0.87

Molecular mechanisms underlying hepatocellular carcinoma. Viruses (2009) 0.87

Enhanced endothelial cell senescence by lithium-induced matrix metalloproteinase-1 expression. J Biol Chem (2009) 0.86

HP1-mediated formation of alternative lengthening of telomeres-associated PML bodies requires HIRA but not ASF1a. PLoS One (2011) 0.86

VentX trans-activates p53 and p16ink4a to regulate cellular senescence. J Biol Chem (2011) 0.86

Wnt signaling potentiates nevogenesis. Proc Natl Acad Sci U S A (2013) 0.86

Axin expression in thymic stromal cells contributes to an age-related increase in thymic adiposity and is associated with reduced thymopoiesis independently of ghrelin signaling. J Leukoc Biol (2009) 0.85

Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria. Elife (2015) 0.85

Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer. Cell Cycle (2013) 0.84

Age-related neuroinflammation and changes in AKT-GSK-3β and WNT/ β-CATENIN signaling in rat hippocampus. Aging (Albany NY) (2015) 0.83

Functional role of inorganic trace elements in angiogenesis part III: (Ti, Li, Ce, As, Hg, Va, Nb and Pb). Crit Rev Oncol Hematol (2015) 0.83

Age-dependent impaired neurogenic differentiation capacity of dental stem cell is associated with Wnt/β-catenin signaling. Cell Mol Neurobiol (2013) 0.82

The effects of aging on the expression of Wnt pathway genes in mouse tissues. Age (Dordr) (2014) 0.81

Dickkopf-1, the Wnt antagonist, is induced by acidic pH and mediates epithelial cellular senescence in human reflux esophagitis. Am J Physiol Gastrointest Liver Physiol (2014) 0.81

The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer. Ann Oncol (2015) 0.80

Noncoding RNA control of cellular senescence. Wiley Interdiscip Rev RNA (2015) 0.79

The Intricate Interplay between Mechanisms Underlying Aging and Cancer. Aging Dis (2014) 0.79

A novel anti-proliferative role of HMGA2 in induction of apoptosis through caspase 2 in primary human fibroblast cells. Biosci Rep (2015) 0.77

A decline in Wnt3a signaling is necessary for mesenchymal stem cells to proceed to replicative senescence. Stem Cells Dev (2015) 0.76

Dual regulation of TERT activity through transcription and splicing by DeltaNP63alpha. Aging (Albany NY) (2008) 0.76

NURD keeps chromatin young. Nat Cell Biol (2009) 0.76

Old cells, new tricks: chromatin structure in senescence. Mamm Genome (2016) 0.76

Physiological and Pathological Aging Affects Chromatin Dynamics, Structure and Function at the Nuclear Edge. Front Genet (2016) 0.75

Changes in mitotic reorientation and Wnt/AR signaling in rat prostate epithelial cells exposed to subchronic testosterone. Exp Ther Med (2016) 0.75

GSK3β activity is essential for senescence-associated heterochromatin foci (SAHF) formation induced by HMGA2 in WI38 cells. Am J Transl Res (2017) 0.75

Differential regulation of the histone chaperone HIRA during muscle cell differentiation by a phosphorylation switch. Exp Mol Med (2016) 0.75

Wnt signaling in regulation of biological functions of the nurse cell harboring Trichinella spp. Parasit Vectors (2016) 0.75

Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for Melanoma. Mol Cancer Res (2016) 0.75

Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling. J Invest Dermatol (2015) 0.75

Global gene profiling of aging lungs in Atp8b1 mutant mice. Aging (Albany NY) (2016) 0.75

HIV and drug abuse mediate astrocyte senescence in a β-catenin-dependent manner leading to neuronal toxicity. Aging Cell (2017) 0.75

Activation of Wnt/β-catenin signaling by lithium chloride attenuates d-galactose-induced neurodegeneration in the auditory cortex of a rat model of aging. FEBS Open Bio (2017) 0.75

The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence. Cancer Lett (2017) 0.75

Articles cited by this

A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A (1995) 32.89

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13

Wnt signalling in stem cells and cancer. Nature (2005) 19.26

BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature (2005) 16.87

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature (2005) 15.83

A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature (2003) 12.81

Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell (2005) 12.73

Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature (2003) 12.54

Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature (2006) 11.76

Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell (2003) 11.40

Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature (2006) 11.18

Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell (2004) 10.16

Tumour biology: senescence in premalignant tumours. Nature (2005) 10.15

Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature (2006) 9.20

Oncogene-induced senescence as an initial barrier in lymphoma development. Nature (2005) 9.16

p16INK4a induces an age-dependent decline in islet regenerative potential. Nature (2006) 9.09

Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature (2006) 8.06

Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science (2002) 7.92

Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet (2004) 7.78

A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell (2006) 6.96

Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell (2004) 6.48

Cellular senescence in aging primates. Science (2006) 6.24

The RCAF complex mediates chromatin assembly during DNA replication and repair. Nature (1999) 5.27

The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev (2007) 4.91

Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev Cell (2005) 4.83

A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell (2006) 4.74

Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat Cell Biol (2006) 4.54

Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A (2005) 4.48

Identification of high-copy disruptors of telomeric silencing in Saccharomyces cerevisiae. Genetics (1998) 4.42

Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration. Cell (2003) 4.38

GSK3 inhibitors: development and therapeutic potential. Nat Rev Drug Discov (2004) 3.93

SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene (2005) 3.77

The role of PML in tumor suppression. Cell (2002) 3.28

Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3. J Biol Chem (1987) 3.19

Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev (2001) 3.16

Accumulation of senescent cells in mitotic tissue of aging primates. Mech Ageing Dev (2006) 3.14

Yeast histone deposition protein Asf1p requires Hir proteins and PCNA for heterochromatic silencing. Curr Biol (2001) 3.14

Cell culture. Progenitor cells from human brain after death. Nature (2001) 2.63

The histone H3.3 chaperone HIRA is essential for chromatin assembly in the male pronucleus. Nature (2005) 2.60

Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol (2006) 2.58

Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol (2007) 2.56

The aging of lympho-hematopoietic stem cells. Nat Immunol (2002) 2.42

Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a). Proc Natl Acad Sci U S A (2006) 2.06

Structure and function of the conserved core of histone deposition protein Asf1. Curr Biol (2003) 2.02

Wnt-1 induces growth, cytosolic beta-catenin, and Tcf/Lef transcriptional activation in Rat-1 fibroblasts. Mol Cell Biol (1998) 1.98

Characterization of HIR1 and HIR2, two genes required for regulation of histone gene transcription in Saccharomyces cerevisiae. Mol Cell Biol (1993) 1.96

Chromosome-wide nucleosome replacement and H3.3 incorporation during mammalian meiotic sex chromosome inactivation. Nat Genet (2007) 1.93

Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene (2007) 1.92

Maize rough sheath2 and its Arabidopsis orthologue ASYMMETRIC LEAVES1 interact with HIRA, a predicted histone chaperone, to maintain knox gene silencing and determinacy during organogenesis. Plant Cell (2005) 1.86

Loss of linker histone H1 in cellular senescence. J Cell Biol (2006) 1.71

Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation. EMBO J (2001) 1.69

Definition of pRB- and p53-dependent and -independent steps in HIRA/ASF1a-mediated formation of senescence-associated heterochromatin foci. Mol Cell Biol (2007) 1.62

Structure of a human ASF1a-HIRA complex and insights into specificity of histone chaperone complex assembly. Nat Struct Mol Biol (2006) 1.58

Histone chaperone ASF1 cooperates with the Brahma chromatin-remodelling machinery. Genes Dev (2002) 1.51

Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axin. Mol Cell Biol (1999) 1.50

HP1 proteins are essential for a dynamic nuclear response that rescues the function of perturbed heterochromatin in primary human cells. Mol Cell Biol (2006) 1.40

Human frizzled 1 interacts with transforming Wnts to transduce a TCF dependent transcriptional response. Oncogene (1999) 1.35

Compartment switching of WNT-2 expression in human breast tumors. Cancer Res (1996) 1.32

Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus. Oncogene (2006) 1.22

Frizzled-9 is activated by Wnt-2 and functions in Wnt/beta -catenin signaling. J Biol Chem (2002) 1.20

Evidence for the involvement of the Wnt 2 gene in human colorectal cancer. Oncogene (1996) 1.15

Nuclear accumulation of glycogen synthase kinase-3 during replicative senescence of human fibroblasts. Aging Cell (2004) 0.98

Recent advances in the molecular genetics of urogenital tumors. Int J Urol (1994) 0.78

Articles by these authors

Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev Cell (2005) 4.83

Defective S phase chromatin assembly causes DNA damage, activation of the S phase checkpoint, and S phase arrest. Mol Cell (2003) 3.23

Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol (2007) 2.56

Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis. Mol Cell (2011) 2.40

Dynamics of histone H3 deposition in vivo reveal a nucleosome gap-filling mechanism for H3.3 to maintain chromatin integrity. Mol Cell (2011) 2.07

Structure and function of the conserved core of histone deposition protein Asf1. Curr Biol (2003) 2.02

Lamin B1 depletion in senescent cells triggers large-scale changes in gene expression and the chromatin landscape. Genes Dev (2013) 1.78

Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. Cell Rep (2013) 1.74

Definition of pRB- and p53-dependent and -independent steps in HIRA/ASF1a-mediated formation of senescence-associated heterochromatin foci. Mol Cell Biol (2007) 1.62

Structure of a human ASF1a-HIRA complex and insights into specificity of histone chaperone complex assembly. Nat Struct Mol Biol (2006) 1.58

Coupling of DNA synthesis and histone synthesis in S phase independent of cyclin/cdk2 activity. Mol Cell Biol (2002) 1.49

Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells. Mol Cancer Res (2010) 1.46

Oncogenic RAS regulates BRIP1 expression to induce dissociation of BRCA1 from chromatin, inhibit DNA repair, and promote senescence. Dev Cell (2011) 1.43

HP1 proteins are essential for a dynamic nuclear response that rescues the function of perturbed heterochromatin in primary human cells. Mol Cell Biol (2006) 1.40

Lysosome-mediated processing of chromatin in senescence. J Cell Biol (2013) 1.38

Senescent cells harbour features of the cancer epigenome. Nat Cell Biol (2013) 1.34

Age-associated increase in heterochromatic marks in murine and primate tissues. Aging Cell (2010) 1.33

Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence. Cancer Res (2011) 1.29

Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B. Blood (2012) 1.29

Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4. Mol Cell Biol (2002) 1.26

Aging by epigenetics--a consequence of chromatin damage? Exp Cell Res (2008) 1.25

Human UBN1 is an ortholog of yeast Hpc2p and has an essential role in the HIRA/ASF1a chromatin-remodeling pathway in senescent cells. Mol Cell Biol (2008) 1.23

Identification of a functional network of human epigenetic silencing factors. J Biol Chem (2009) 1.20

Recurrent fever promotes Plasmodium falciparum development in human erythrocytes. J Biol Chem (2004) 1.20

Placing the HIRA histone chaperone complex in the chromatin landscape. Cell Rep (2013) 1.16

Heterochromatin and its relationship to cell senescence and cancer therapy. Cell Cycle (2007) 1.09

Three-dimensional culture sensitizes epithelial ovarian cancer cells to EZH2 methyltransferase inhibition. Cell Cycle (2013) 1.08

Dibasic phosphorylation sites in the R domain of CFTR have stimulatory and inhibitory effects on channel activation. Am J Physiol Cell Physiol (2004) 1.06

Varicella-zoster virus immediate-early 63 protein interacts with human antisilencing function 1 protein and alters its ability to bind histones h3.1 and h3.3. J Virol (2008) 1.06

Identification of cellular proteins that maintain retroviral epigenetic silencing: evidence for an antiviral response. J Virol (2007) 1.06

Senescent mouse cells fail to overtly regulate the HIRA histone chaperone and do not form robust Senescence Associated Heterochromatin Foci. Cell Div (2010) 1.05

ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches. Cancer Prev Res (Phila) (2011) 1.03

SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRK. Mol Cancer Res (2012) 1.03

Human CABIN1 is a functional member of the human HIRA/UBN1/ASF1a histone H3.3 chaperone complex. Mol Cell Biol (2011) 1.00

A comparison of oncogene-induced senescence and replicative senescence: implications for tumor suppression and aging. Age (Dordr) (2014) 0.98

Protein isoform-specific validation defines multiple chloride intracellular channel and tropomyosin isoforms as serological biomarkers of ovarian cancer. J Proteomics (2013) 0.97

Current status of cleaning and disinfection for gastrointestinal endoscopy in China: a survey of 122 endoscopy units. Dig Liver Dis (2011) 0.97

EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells. J Exp Clin Cancer Res (2013) 0.96

BRG1 is required for formation of senescence-associated heterochromatin foci induced by oncogenic RAS or BRCA1 loss. Mol Cell Biol (2013) 0.95

DNMT inhibitors reverse a specific signature of aberrant promoter DNA methylation and associated gene silencing in AML. Genome Biol (2014) 0.95

NF-YA underlies EZH2 upregulation and is essential for proliferation of human epithelial ovarian cancer cells. Mol Cancer Res (2013) 0.93

Diagnosis and surgical treatment of esophageal leiomyoma. Zhonghua Zhong Liu Za Zhi (2002) 0.92

Detection of senescence-associated heterochromatin foci (SAHF). Methods Mol Biol (2013) 0.90

Identification of an ubinuclein 1 region required for stability and function of the human HIRA/UBN1/CABIN1/ASF1a histone H3.3 chaperone complex. Biochemistry (2012) 0.89

Role of EZH2 in Epithelial Ovarian Cancer: From Biological Insights to Therapeutic Target. Front Oncol (2013) 0.89

Senescence at a glance. J Cell Sci (2013) 0.88

Profiling of transcriptional and epigenetic changes during directed endothelial differentiation of human embryonic stem cells identifies FOXA2 as a marker of early mesoderm commitment. Stem Cell Res Ther (2013) 0.87

A novel role for the condensin II complex in cellular senescence. Cell Cycle (2015) 0.87

Transcription factors, cAMP-responsive element modulator (CREM) and Tisp40, act in concert in postmeiotic transcriptional regulation. J Biol Chem (2006) 0.87

Wnt signaling potentiates nevogenesis. Proc Natl Acad Sci U S A (2013) 0.86

Activation of Wnt signalling promotes development of dysplasia in Barrett's oesophagus. J Pathol (2012) 0.85

POT1 deficiency alters telomere length and telomere-associated gene expression in human gastric cancer cells. Eur J Cancer Prev (2010) 0.84

BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumors. Am J Surg Pathol (2014) 0.83

Lessons from senescence: Chromatin maintenance in non-proliferating cells. Biochim Biophys Acta (2011) 0.82

Identification of multiple novel protein biomarkers shed by human serous ovarian tumors into the blood of immunocompromised mice and verified in patient sera. PLoS One (2013) 0.81

The effects of aging on the expression of Wnt pathway genes in mouse tissues. Age (Dordr) (2014) 0.81

A damage limitation exercise. Nat Cell Biol (2011) 0.80

Genome-wide promoter methylome of small renal masses. PLoS One (2013) 0.80

Signalling the end of the line. Nat Cell Biol (2012) 0.80

The Sno oncogene antagonizes Wingless signaling during wing development in Drosophila. PLoS One (2010) 0.79

Ras, PI3K/Akt and senescence: Paradoxes provide clues for pancreatic cancer therapy. Small GTPases (2011) 0.79

Chromatin remodeling, BRCA1, SAHF and cellular senescence. Cell Cycle (2013) 0.79

Comparison of gastrotomy closure modalities for natural orifice transluminal surgery: a canine study. Gastrointest Endosc (2013) 0.79

A high-content screening assay for small-molecule modulators of oncogene-induced senescence. J Biomol Screen (2013) 0.79

Microarray-based identification of age-dependent differences in gene expression of human dermal fibroblasts. Mech Ageing Dev (2012) 0.79

Coordination of S-phase events and genome stability. Cell Cycle (2003) 0.79

Chromatin: a molecular interface between cancer and aging. Curr Opin Genet Dev (2010) 0.78

Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling. J Invest Dermatol (2015) 0.78

RAS, cellular senescence and transformation: the BRCA1 DNA repair pathway at the crossroads. Small GTPases (2012) 0.76

A two-step two-hybrid system to identify functionally significant protein-protein interactions. Methods (2004) 0.76

Design and application of a shRNA-based gene replacement retrovirus. Methods Mol Biol (2007) 0.76

"Plasmo2D": an ancillary proteomic tool to aid identification of proteins from Plasmodium falciparum. J Proteome Res (2005) 0.76

Comprehensive analysis of the ubiquitinome during oncogene-induced senescence in human fibroblasts. Cell Cycle (2015) 0.76

Corrigendum: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. Nature (2016) 0.75

Clipped wings: epigenetic inactivation of APC. Cancer Biol Ther (2004) 0.75

Reconstruction of sacral defects following necrosis of buttocks due to embolization of internal iliac artery using a transverse lumbar flap. Can J Plast Surg (2009) 0.75

Biochemical analysis of the cell cycle and cell cycle checkpoints in transiently transfected cells after collection with magnetic beads. Methods Mol Biol (2004) 0.75

[99mTc-Pingyangmycin imaging in the diagnosis of primary lung cancer]. Zhonghua Zhong Liu Za Zhi (2002) 0.75

DSM-5-defined attenuated psychosis syndrome and conversion to full-scale schizophrenia spectrum disorders: An institution-wide retrospective review. Ann Clin Psychiatry (2016) 0.75

[Surgical treatment for lung cancer patients with poor pulmonary function]. Zhonghua Zhong Liu Za Zhi (2002) 0.75

[Clinical value of prophylactic radiotherapy after curative resection of esophageal carcinoma]. Zhonghua Zhong Liu Za Zhi (2002) 0.75

[Management of perioperative respiratory problems in patients with tumor of trachea or carina]. Zhonghua Zhong Liu Za Zhi (2002) 0.75

[Thoracoscopy and thoracotomy for lung biopsy and wedge resection in solitary pulmonary nodule]. Zhongguo Fei Ai Za Zhi (2004) 0.75